Align Technology (ALGN)
Health Care · Medical Devices & Supplies · NASDAQ
Align Technology provides digital dental solutions including the Invisalign system and iTero intraoral scanners to transform orthodontic and restorative care.
What Align Technology does
Align Technology is a global medical device company that designs, manufactures, and markets the Invisalign system of clear aligners and iTero intraoral scanners and services. Its solutions are used by orthodontists and general practitioner dentists to transform and improve the delivery of dental care through digital workflows. The company focuses on the orthodontic and restorative dentistry markets.
Themes: digital dentistry, orthodontics, medical technology, aesthetic dentistry
Fundamentals
- Price$150.50 as of 2026-10-20 close
- Market cap$10.7B as of 2026-07-31 (share count; price 2026-10-20)
- 1-year return+11.5% 2025-10-20 close $134.93 → 2026-10-20 close $150.50
- P/E26.13 as of 2026-10-20
- Net margin+10.2% FY2025, SEC XBRL
- Gross margin+67.2% FY2025, SEC XBRL
- ROE+10.1% FY2025, SEC XBRL
- ROICn/a No figure: its filing tags none of the debt lines we read, which is not evidence of zero debt.
- Debt / equityn/a No figure: its filing tags none of the debt lines we read, which is not evidence of zero debt.
- Revenue growth (YoY)+0.9% FY2025, SEC XBRL
- Revenue CAGR (3y)+2.6% SEC XBRL
- Beta1.26 as of 2026-09-03
- Last reported earnings2026-07-29 SEC EDGAR Form 8-K (Item 2.02)
How ALGN compares in its sector
- price-to-earnings ratiomiddle range 181 covered Health Care peers, as of 2026-10-20
- net profit margintop 25% 430 covered Health Care peers, as of 2026-09-03
- operating margintop 25% 417 covered Health Care peers, as of 2026-09-03
- gross marginmiddle range 189 covered Health Care peers, as of 2026-09-03
- return on equitytop 25% 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 25% 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
ALGN is not currently in any published Top 10 list. Its scores are below.
Top 10 score
45.9 #881 of 1,265 scored · #110 of 146 in Health Care
Valuation 60th (price to book 2.5, price to earnings 26.1) and financial health 56th (free cash flow margin 12.2%); weakest is growth (26th, revenue growth year over year 0.9%, 3-year revenue CAGR 2.6%).
Scores as of 20 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Quarterly results
| Quarter | Revenue | Gross profit | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-30 | $1.1B | $757M | $154M | $108M | $1.51 | $193M† | $36M† |
| Q1 FY2026 2026-03-31 | $1.0B | $737M | $142M | $113M | $1.57 | $151M | $31M |
| Q4 FY2025 2025-12-31 | $1.0B† | $684M† | $155M† | $136M† | $1.88† | $223M† | $36M† |
| Q3 FY2025 2025-09-30 | $996M | $639M | $96M | $57M | $0.78 | $189M† | $20M† |
| Q2 FY2025 2025-06-30 | $1.0B | $708M | $163M | $125M | $1.72 | $129M† | $21M† |
| Q1 FY2025 2025-03-31 | $979M | $680M | $131M | $93M | $1.27 | $53M | $25M |
| Q4 FY2024 2024-12-31 | $995M† | $697M† | $144M† | $104M† | $1.39† | $286M† | $23M† |
| Q3 FY2024 2024-09-30 | $978M | $682M | $162M | $116M | $1.55 | $264M† | $30M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$1.1B
- Total debtnot shown the filing tags none of the debt lines we read — not evidence of zero debt
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How Align Technology looks technically
Align Technology (ALGN) is trading 11.0% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 29 trading days ago — a "death cross", a bearish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 23 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 55, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 9 trading days ago (its momentum flipped positive). It made a new 20-day low about 10 trading days ago. It is 24.8% below its highest point of the past year. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 2% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 11.0% below its 200-day average, the long-term trend line — a long-term downtrend | -11.0% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $153.31 | $153.31 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $169.17 | $169.17 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 12 calendar days ago — the swings before that are what the structure reading is measured on | 12 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 164.74. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible downward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 29 trading days ago — a "death cross", a bearish long-term signal | 29 sessions |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 23 (a reading of 25+ marks a strong trend) | 23.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 55, neither overbought (above 70) nor oversold (below 30) | 54.8 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($138.05 to $152.27) — its "stochastic" reading is 88 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 87.5 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 9 trading days ago (its momentum flipped positive) | 9 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $200.25 | $200.25 |
|---|---|---|
| From the 52-week high | it is 24.8% below its 52-week high (its highest price of the past year) | -24.9% |
| Above the 52-week low | it is 17.8% above its 52-week low (its lowest price of the past year) | +17.8% |
| Below the 52-week high | it is 24.8% below its highest point of the past year | 24.9% |
| Since a 20-day breakout | it made a new 20-day low about 10 trading days ago | 10 sessions |
| Since a 55-day breakout | it made a new 55-day low about 10 trading days ago | 10 sessions |
| All-time high | its highest closing price on record is $737.45 (set on 2021-09-23) | $737.45 |
| Given back of the 52-week move | over the past year its closes ranged ($128.43 to $197.51), and it has given back well over two thirds of its rise from last year’s low — 68% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $152.61 to $154.82. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 68.1% |
| From the all-time high | it is 79.6% below its all-time high | -79.6% |
| Nearest price level | it is sitting right on a resistance level at $150.86 — a price it turned at three times since 2025-08-22, most recently on 2026-05-20. Since 2024-10-21 it has 2 such levels below the current price and 11 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.2% |
| All-time low | its lowest closing price on record is $4.88 (set on 2008-10-24) | $4.88 |
| Above the all-time low | it is 2983.9% above its all-time low | +2,984% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 2% of the past ~6 months), which often precedes a bigger move | 2nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $4.29 between its high and its low — about 2.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $4.29 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $138.59 and $150.84 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $138.59 – $144.71 – $150.84 |
| Typical daily range (% of price) | its price moves about 2.9% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.9% |
| Stretch from the 200-day average | it is trading 4.4 daily ranges below its 200-day average price (11.0% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 4.4 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.96× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 1.9% since the prior reading | -1.9% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a bullish engulfing | 8 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 8 sessions ago |
|---|---|---|
| Since a bearish engulfing | 6 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 6 sessions ago |
Price gaps
2
| Gap at the open | it opened on 2026-10-20 0.3% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.3% |
|---|---|---|
| Gap filled | a 2.6% gap down opened on 2026-10-05 has been "filled" 6 sessions ago — price traded back through the level the gap left behind, and it took 5 sessions to close | 6 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +2.16% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 1.0 percentage points (the stock gained 2.0% while the market gained 1.0%) | +1.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 17.7 percentage points (the stock lost 14.0% while the market gained 3.6%) | -17.7% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 30.0 percentage points (the stock lost 21.5% while the market gained 8.5%) | -30.0% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 3.0 percentage points (the stock gained 11.5% while the market gained 14.6%) | -3.0% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: MACD momentum is positive — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, near the top of its 14-day range (overbought), trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 6.3% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 6.1% of the share price. | -6.3% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 12% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $170.11 — a volume-weighted average of daily closes over 198 sessions, not a true tick-by-tick VWAP. | -11.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is 4% below the average price paid since it last reported on 2026-07-29 (its 8-K), so the typical buyer over that stretch is under water. That average is $156.42 — a volume-weighted average of daily closes over 59 sessions, not a true tick-by-tick VWAP. | -3.8% |
Price levels it has turned at before
ALGN last closed at $150.50 on 2026-10-20. Since 2024-10-21 it has turned at 2 prices below its last close and 11 above; the 2 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $150.86 | Resistance | 0.2% above the last close | turned there three times · 2025-08-22 to 2026-05-20 |
| $154.56 | Resistance | 2.7% above the last close | turned there three times · 2026-01-02 to 2026-09-22 |
| $141.06 | Support | 6.3% below the last close | turned there twice · 2025-04-08 to 2025-09-09 |
| $163.95 | Resistance | 8.9% above the last close | turned there six times · 2026-01-20 to 2026-09-03 |
| $130.96 | Support | 13.0% below the last close | turned there four times · 2025-09-04 to 2025-11-18 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $164.74.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $148.47 and $160.13 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close below $138.05.
This reading has stood for 4 trading days, since 2026-10-15.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Recent death cross (50-day crossed below 200-day) · Pulled back from the 12-month high · in a Bollinger Band volatility squeeze · Analyst price target recently CUT | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low · bollinger bands
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.25 mean, 1=Strong Buy…5=Strong Sell) — 14 analysts
- Mean price target$193.79 range $155.00 – $235.00; median $197.00
Analyst estimates, as of 2026-10-21. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ALGN
- Consensus EPS estimate$2.78 next reporting period, as of 2026-10-21
- Estimate change, 30 days-$0.01388 (-0.5%) from $2.79, on 2026-09-21, 30-day window
- Readings revised upward0% of 11 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on demand for elective dental procedures which can be sensitive to macroeconomic conditions and consumer spending.","Significant competition from established and emerging dental device manufacturers.","Risks associated with international operations, including regulatory compliance, currency fluctuations, and geopolitical tensions."]
What changed in the latest 10-Q
AI-assisted comparison of ALGN's 10-Q filed 2026-08-05 against the prior one filed 2026-05-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-05) adds a 'Recent Developments' subsection under 'Executive Overview of Results' that was not present in the older filing (2026-05-06).
- Newer filing (2026-08-05) adds a paragraph announcing plans for a new manufacturing facility in Hyderabad, India, expected to commence operations in 2027, representing Align Technology's first manufacturing facility in India, with expected investment of approximately $200 million over the next several years and stated goals of supporting growth in high-demand markets, enhancing supply chain resiliency, increasing manufacturing capacity, improving operational efficiency, and further diversifying the global manufacturing footprint.
- Newer filing (2026-08-05) adds a 'UK VAT Update' paragraph describing a July 7, 2026 Upper Tribunal (Tax and Chancery Chamber) decision reversing the April 24, 2025 First-tier Tribunal decision and holding that clear aligners are not dental prostheses and are subject to UK VAT at the standard rate.
- Newer filing (2026-08-05) adds disclosure of an estimated liability of approximately $37.5 million recorded as of June 30, 2026 related to the UK VAT matter, described as management's best estimate of the obligation as of the reporting date.
- Newer filing (2026-08-05) adds a statement that the company intends to exhaust all available appeals and vig... (text truncated in source).
- Removed:
- Older filing (2026-05-06) includes 'elevated gasoline and other energy costs' in the forward-looking statements list of macroeconomic conditions; this phrase is absent from the newer filing (2026-08-05).
- Older filing (2026-05-06) includes the phrase 'in light of recent U.S. Supreme Court decision on the constitutionality of tariffs' regarding retaliatory actions by other nations; this phrase is absent from the newer filing (2026-08-05).
- Older filing (2026-05-06) includes 'and potential collaboration opportunities' in the forward-looking statements regarding target markets; this phrase is absent from the newer filing (2026-08-05).
- Older filing (2026-05-06) includes forward-looking statements regarding 'the timing and amount of future stock repurchases'; this item is absent from the newer filing (2026-08-05).
- Older filing (2026-05-06) includes 'including value-added tax positions and related contingent liabilities' in the forward-looking statements about tax obligations; this phrase is absent from the newer filing (2026-08-05).
- Older filing (2026-05-06) includes statements regarding restructuring plans, workforce reductions, and related charges and savings; these statements are absent from the newer filing (2026-08-05).
- Older filing (2026-05-06) includes statements regarding acquisitions, dispositions, divestitures, held-for-sale classifications, and related fair-value estimates and measurement-period adjustments; these statements are absent from the newer filing (2026-08-05).
- Older filing (2026-05-06) includes a statement regarding beliefs about culture and commitment and its impact on financial and operational performance and its importance to future success; this statement is absent from the newer filing (2026-08-05).
- Older filing (2026-05-06) includes a 'Trends and Uncertainties' section following 'Our Strategic Growth Drivers'; this section is not present in the portion of the newer filing (2026-08-05) provided.
- Reworded:
- Newer filing (2026-08-05) changes forward-looking statements regarding manufacturing operations to add 'and our plans to open a manufacturing facility in Hyderabad, India in 2027'; the older filing (2026-05-06) only references beliefs regarding the importance of manufacturing operations on success without the Hyderabad plan.
- Newer filing (2026-08-05) adds 'elevated gasoline and other energy costs' to the list of macroeconomic conditions while removing the qualifier 'in light of recent U.S. Supreme Court decision on the constitutionality of tariffs' regarding retaliatory actions by other nations that appeared in the older filing (2026-05-06). (Note: assessment of this phrase is uncertain due to potential text truncation.)
- Newer filing (2026-08-05) adds 'our expectations regarding the outcomes and timing of ongoing litigation matters and regulatory developments' to the forward-looking statements list; the older filing (2026-05-06) does not contain this item.
- Newer filing (2026-08-05) rearranges the paragraph break location in the Strategic Growth Drivers section: 'digital transformation of' and 'dentistry, our continuous focus...' appear together in the newer filing, while the older filing has a page break between 'digital transformation of' and 'dentistry, our continuous focus'.
- Notes:
- The newer filing text appears to be truncated at the end of the UK VAT Update paragraph ('We intend to exhaust all available appeals and vig...'), preventing complete comparison of that paragraph.
- The older filing text appears to be truncated at the end ('For example, we believe that in the beginning of the second quarter of 2025, sales of our pr...'), preventing comparison of the full 'Trends and Uncertainties' section.
- The newer filing excerpt does not include a 'Trends and Uncertainties' section, but because the source texts are partial excerpts, it cannot be determined whether the section was removed or simply not present in the provided portion.
Risk Factors
- Added:
- Newer filing (2026-08-05) states the U.S. Department of Commerce 'has completed' its Section 232 investigation into imports of PPE, medical consumables, and medical equipment including devices; the older filing (2026-05-06) stated the Department 'has initiated' the investigation.
- Newer filing (2026-08-05) adds the sentence: 'No actions with respect to the investigation have been announced to date, and the timing, scope and outcome of any resulting trade measures remain uncertain.'
- Removed:
- Older filing (2026-05-06) contained the sentence: 'Tariffs have and could in the future result in additional costs' at the end of the section; the newer filing text is truncated and ends mid-sentence ('ship th'), so the presence of this sentence in the newer filing cannot be confirmed.
- Reworded:
- In the tariff passage, older filing (2026-05-06) says the Department of Commerce 'has initiated an investigation'; newer filing (2026-08-05) says it 'has completed its investigation' under Section 232.
- Newer filing (2026-08-05) includes a new sentence about uncertainty regarding actions, timing, scope, and outcome of trade measures following the Section 232 investigation that is absent from the older filing (2026-05-06).
- Notes:
- The newer filing text is truncated mid-sentence at 'ship th', so changes after that point cannot be assessed.
- The older filing text is truncated mid-sentence at 'result in additional costs', so changes after that point cannot be assessed.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for ALGN — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 5 matched disclosures for ALGN from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding ALGN as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 12,152,938
- Reported value $2,049,714,596
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 5 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ALGN's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ALGN had 4,202,648 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
ALGN had 5.92% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.3 days to cover at the same settlement.
- Reported short interest (shares) 4,202,648
- Short interest (% of shares outstanding) 5.92%
- Prior settlement (shares) 3,901,037
- Reported change 7.73%
- Days to cover (reported) 4.3
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Envista Holdings (NVST)
- Dentsply Sirona (XRAY)
- Straumann Group (STMN.SW)
- Henry Schein (HSIC)
- 3M Company (MMM)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ALGN vs…
Align Technology is found in…
Frequently asked questions
What does Align Technology (ALGN) do?
Align Technology is a global medical device company that designs, manufactures, and markets the Invisalign system of clear aligners and iTero intraoral scanners and services. Its solutions are used by orthodontists and general practitioner dentists to transform and improve the delivery of dental care through digital workflows. The company focuses on the orthodontic and restorative dentistry markets.
What sector is Align Technology (ALGN) in?
Align Technology (ALGN) is classified in the Health Care sector. Its industry is Medical Devices & Supplies. It trades on NASDAQ.
Who are Align Technology's (ALGN) competitors?
Notable peers of Align Technology (ALGN) include Envista Holdings, Dentsply Sirona, Straumann Group, Henry Schein and 3M Company. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in ALGN?
Yes — we hold 5 matched STOCK Act disclosures for ALGN from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Align Technology (ALGN) overbought or oversold right now?
Align Technology (ALGN) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 55, in the neutral middle (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ALGN come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.